1-4 of 4
Harry Ramos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors

Ali Al Sbihi, Sushmitha Nanja Reddy, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Abdul Moiz Khan, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6189–6190.
https://doi.org/10.1182/blood-2022-171131
Published: 2022
Journal Articles

Real-World Outcomes and Cardiac Implications of FLT3 Inhibitors in Acute Myeloid Leukemia

Vikram Dhillon, Abdul Moiz Khan, Ali Al Sbihi, Sushmitha Nanja Reddy, Enxhi Lalo, Harry Ramos, Jay Yang, Anupama Kottam, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6183–6184.
https://doi.org/10.1182/blood-2022-169932
Published: 2022
Journal Articles

A Systematic Review and Meta-Analysis Comparing Type I and II FLT3 Inhibitors in Relapsed/ Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Mai M M Aly, Mahesh Swaminathan, Katherine G. Akers, Seongho Kim, Harry Ramos, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2021) 138 (Supplement 1): 1249.
https://doi.org/10.1182/blood-2021-148902
Published: 2021
Journal Articles

Efficacy Analysis of Different FLT3 Inhibitors in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Patients - a Systematic Review and Meta-Analysis

Mahesh Swaminathan, Mai M M Aly, Katherine G. Akers, Seongho Kim, Harry Ramos, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2021) 138 (Supplement 1): 1225.
https://doi.org/10.1182/blood-2021-154098
Published: 2021